Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
6
×
national blog main
fda
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
europe top stories
indiana blog main
indiana top stories
national
new york blog main
novartis
roche
san diego blog main
san diego top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe blog main
investing
medical devices
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
type 1 diabetes
venture capital
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
What
patients
6
×
drug
fda
daily
market
medicine
new
type
add
advantages
analytics
approval
approved
atrophy
bar
bid
bio
biofourmis
boehringer
brings
called
cancer
carbidopa
combination
control
data
devices
diabetes
digital
disease
eisai
eli
employs
evrysdi
expand
expect
experience
fallen
flags
friday
Language
unset
6
×
Current search:
patients
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone